. 2021 Jan;10(1):57–64. doi: 10.21037/tcr-20-2370

Table 1. Clinical and pathologic characteristics of the CRC cases with MET and miR-133b mRNA expression.

Clinicopathological features	Number	miR-133b			MET
Clinicopathological features	Number	Low^a (n=23)	High^a (n=23)	P value	Low^a (n=23)	High^a (n=23)	P value
Age (years)	46
≥60	34	15	19	0.397	20	14	0.318
<60	12	7	5		9	3
Tumor site^b
Right	13	7	6	0.528	4	9	0.178
Left	7	2	5		3	4
Rectum	26	13	13		16	10
Tumor differentiation
Well	2	0	2	0.138	1	1	0.712
Moderate	28	11	17		12	16
Poor	16	10	6		5	11
Staging
I	6	3	3	0.432	4	2	0.677
II	11	6	5		7	4
III	25	19	6		12	13
IV	4	4	0		0	4
Lymph node
N0	18	5	13	0.028^b	10	8	0.032^b
N1	21	8	13		17	4
N2	7	6	1		2	5
Distant metastasis
M0	42	17	25	0.022^b	31	11	0.003^b
M1	4	4	0		0	4

^a, low and high expression groups were determined by the median value of MET and miR-133b mRNA in the tumor tissue specimens; ^b, statistical significance (P<0.05). CRC, colorectal cancer; MET, mesenchymal-epithelial transition factor.